Secretory proteins of Mycobacterium habana induce a protective immune response against experimental tuberculosis

FEMS Immunology and Medical Microbiology

Volumn 26, Issue 2, 1999, Pages 143-151

  Chaturvedi, Vinita ^a   Jyoti, Divya ^a   Srivastava, Sudhir ^a   Gupta, Hardwar P ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Mycobacterium habana; Mycobacterium tuberculosis; Protection; Secretory protein

Indexed keywords

MYCOBACTERIUM VACCINE; SECRETORY PROTEIN;

ANIMAL MODEL; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; IMMUNE RESPONSE; INTRADERMAL DRUG ADMINISTRATION; MALE; MOUSE; MYCOBACTERIUM; MYCOBACTERIUM HABANA; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; TUBERCULOSIS;

ANIMALS; BACTERIAL PROTEINS; COLONY COUNT, MICROBIAL; IMMUNIZATION; LUNG; MALE; MICE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; SPLEEN; TUBERCULOSIS; VACCINATION;

EID: 0032834318     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(99)00134-0     Document Type: Article

References (29)

1. World Health Organization (1977) Global Tuberculosis Programme Annual Report: WHO Report on the Tuberculosis Epidemic. WHO, Geneva.
2. Styblo K. The impact of HIV infection on the global epidemiology of tuberculosis. Bull. Int. Union Against Tuberc. Lung Dis. 66:1991;27-30.
3. WHO/IUATLD (1997) Antituberculosis Drug Resistance in the World, WHO/TB/97.229. WHO, Geneva.
4. Spingett V.H., Sutherland I. A reexamination of the variation in the efficacy of BCG vaccination against tuberculosis in clinical trials. Tuberc. Lung Dis. 75:1994;227.
5. Convit J., Sampson C., Zuniga M., et al. Immunoprophylactic trial with combined Mycobacterium leprae/BCG vaccine against leprosy: preliminary results. Lancet. 339:1992;446-450.
6. Moreno C., Mahlert A., Lamb J. The inhibitory effects of mycobacterial lipoarabinomannan and polysaccharides upon polyclonal and monoclonal human T-cell proliferation. Clin. Exp. Immunol. 74:1988;206-210.
7. Nagai S., Tanaka A. Necrotic inflammatory reaction induced by muramyl dipeptide in guinea pigs sensitized by tubercle bacilli. J. Exp. Med. 162:1985;401-412.
8. Shoenfield Y., Isenberg D.A. Mycobacteria and autoimmunity. Immunol. Today. 9:1988;178-182.
9. Sibley L.D., Adams L.B., Krahenbuhl J.L. Inhibition of interferon gamma mediated activation in mouse macrophage treated with lipoarabinomannan. Clin. Exp. Immunol. 80:1990;141-148.
10. Vachula M., Holzer T.J., Kizlaitis L., Anderson B.R. Effect of M. leprae's phenolic glycolipid-I on interferon gamma augmentation of monocyte oxidative responses. Int. J. Lepr. 58:1990;342-346.
11. Kaufmann S.H.E., Young D.B. Vaccination against tuberculosis and leprosy. Immunobiology. 184:1992;208-229.
12. Sinha R.K., Verma I., Khuller G.K. Immunobiological properties of a 30kDa secretory protein of Mycobacterium tuberculosis H37Ra. Vaccine. 15:1997;689-699.
13. Horwitz M.A., Lee B.W.E., Dhillon B.J., Harth G. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of M. tuberculosis. Proc. Natl. Acad. Sci. USA. 92:1995;1530-1534.
14. Andersen P., Askgaard D., Ljungqvist L., Bentzan M.W., Heron I. T-cell proliferative response to antigens secreted by M. tuberculosis. Infect. Immun. 56:1991;1558-1563.
15. Orme I.M. Induction of nonspecific acquired resistance and delayed type hypersensitivity but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines. Infect. Immun. 56:1988;3310-3312.
16. Pal P.G., Horwitz M.A. Immunization with extracellular proteins of M. tuberculosis induces cell mediated immunity in a guinea pig model of pulmonary tuberculosis. Infect. Immun. 60:1992;4781-4792.
17. Gupta H.P., Mathur I.S., Singh N.B. Protective effect of Mycobacterium habana in mice against infection with indigenous strains of Mycobacterium tuberculosis. Curr. Sci. 53:1984;695-697.
18. Singh N.B., Srivastava K., Malaviya B., Kandpal H., Srivastava A., Gupta H.P. The 65 kDa protein of Mycobacterium habana and its putative role in immunity against experimental tuberculosis. Immunol. Cell Biol. 73:1995;372-376.
19. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.F. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
20. Laemmli U.K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
21. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
22. Fenner F. The enumeration of viable tubercle bacilli by surface counts. Am. Rev. Tuberc. Dis. 64:1951;252-383.
23. Nagai S., Matsumoto J., Nagasuga T. Specific skin reactive protein from culture filtrate of M. bovis BCG. Infect. Immun. 31:1981;1152-1160.
24. Turcotte R. Yields of nondialysable mycobacterial constituents during the growth cycle. Can. J. Microbiol. 15:1969;35-41.
25. Turcotte R., Desormeaux Y. Influence of the age of mycobacterial cultures on the protein and carbohydrate composition of M. tuberculosis. Can. J. Microbiol. 18:1972;637-645.
26. Collins F.M., Lamb J.R., Young D.B. Biological activity of protein antigens isolated from M. tuberculosis culture filtrate. Infect. Immun. 56:1988;1260-1266.
27. Havlir D.V., Wallis R.S., Boom W.H., Daniel T.M., Chervanak K., Elner J.J. Human immune response to Mycobacterium tuberculosis antigens. Infect. Immun. 59:1991;665-670.
28. Andersen P., Heron I. Specificity of a protective memory immune response against Mycobacterium tuberculosis. Infect. Immun. 61:1993;844-851.
29. Gupta H.P., Singh N.B., Mathur I.S., Gupta S.K. Mycobacterium habana, a new immunogenic strain in experimental tuberculosis in mice. Indian J. Exp. Biol. 17:1979;1190-1193.